These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33968856)

  • 1.
    Lin Z; Li J; Ji T; Wu Y; Gao K; Jiang Y
    Front Pediatr; 2021; 9():657256. PubMed ID: 33968856
    [No Abstract]   [Full Text] [Related]  

  • 2. Hereditary spastic paraplegia is a novel phenotype for germline de novo ATP1A1 mutation.
    Stregapede F; Travaglini L; Rebelo AP; Cintra VP; Bellacchio E; Bosco L; Alfieri P; Pro S; Zuchner S; Bertini E; Nicita F
    Clin Genet; 2020 Mar; 97(3):521-526. PubMed ID: 31705535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline De Novo Mutations in ATP1A1 Cause Renal Hypomagnesemia, Refractory Seizures, and Intellectual Disability.
    Schlingmann KP; Bandulik S; Mammen C; Tarailo-Graovac M; Holm R; Baumann M; König J; Lee JJY; Drögemöller B; Imminger K; Beck BB; Altmüller J; Thiele H; Waldegger S; Van't Hoff W; Kleta R; Warth R; van Karnebeek CDM; Vilsen B; Bockenhauer D; Konrad M
    Am J Hum Genet; 2018 Nov; 103(5):808-816. PubMed ID: 30388404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De Novo
    Dohrn MF; Rebelo AP; Srivastava S; Cappuccio G; Smigiel R; Malhotra A; Basel D; van de Laar I; Neuteboom RF; Aarts-Tesselaar C; Mahida S; Brunetti-Pierri N; Taft RJ; Züchner S
    Neurology; 2022 Mar; 98(11):440-445. PubMed ID: 35110381
    [No Abstract]   [Full Text] [Related]  

  • 5. The phenotypic spectrum of pathogenic ATP1A1 variants expands: the novel p.P600R substitution causes demyelinating Charcot-Marie-Tooth disease.
    Cinarli Yuksel F; Nicolaou P; Spontarelli K; Dohrn MF; Rebelo AP; Koutsou P; Georghiou A; Artigas P; Züchner SL; Kleopa KA; Christodoulou K
    J Neurol; 2023 May; 270(5):2576-2590. PubMed ID: 36738336
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Zhang L; Wen Y; Zhang Q; Chen Y; Wang J; Shi K; Du L; Bao X
    Front Pediatr; 2020; 8():577544. PubMed ID: 33425808
    [No Abstract]   [Full Text] [Related]  

  • 7.
    Zhang H; Wu Y; Jiang Y
    Front Pediatr; 2021; 9():699568. PubMed ID: 34604137
    [No Abstract]   [Full Text] [Related]  

  • 8. Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy.
    Kanani F; Titheradge H; Cooper N; Elmslie F; Lees MM; Juusola J; Pisani L; McKenna C; Mignot C; Valence S; Keren B; Lachlan K; ; Balasubramanian M
    Am J Med Genet A; 2020 Apr; 182(4):713-720. PubMed ID: 31926053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the genotypic and phenotypic spectrum associated with TBL1XR1 de novo variants.
    Ren M; Zheng H; Lu X; Lian W; Feng B
    Gene; 2023 Nov; 886():147777. PubMed ID: 37683765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyond.
    Marini C; Porro A; Rastetter A; Dalle C; Rivolta I; Bauer D; Oegema R; Nava C; Parrini E; Mei D; Mercer C; Dhamija R; Chambers C; Coubes C; Thévenon J; Kuentz P; Julia S; Pasquier L; Dubourg C; Carré W; Rosati A; Melani F; Pisano T; Giardino M; Innes AM; Alembik Y; Scheidecker S; Santos M; Figueiroa S; Garrido C; Fusco C; Frattini D; Spagnoli C; Binda A; Granata T; Ragona F; Freri E; Franceschetti S; Canafoglia L; Castellotti B; Gellera C; Milanesi R; Mancardi MM; Clark DR; Kok F; Helbig KL; Ichikawa S; Sadler L; Neupauerová J; Laššuthova P; Šterbová K; Laridon A; Brilstra E; Koeleman B; Lemke JR; Zara F; Striano P; Soblet J; Smits G; Deconinck N; Barbuti A; DiFrancesco D; LeGuern E; Guerrini R; Santoro B; Hamacher K; Thiel G; Moroni A; DiFrancesco JC; Depienne C
    Brain; 2018 Nov; 141(11):3160-3178. PubMed ID: 30351409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diseases caused by mutations in the Na
    Biondo ED; Spontarelli K; Ababioh G; Méndez L; Artigas P
    Am J Physiol Cell Physiol; 2021 Aug; 321(2):C394-C408. PubMed ID: 34232746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo mutations of TUBB2A cause infantile-onset epilepsy and developmental delay.
    Cai S; Li J; Wu Y; Jiang Y
    J Hum Genet; 2020 Jul; 65(7):601-608. PubMed ID: 32203252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo variants in PHF21A cause intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures: A case report and literature review.
    Chen H; Chen Y; Wu H; Qiu X; Yu X; Wang R; Zhong J; Peng J
    Seizure; 2023 Oct; 111():138-146. PubMed ID: 37633153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodevelopmental Disorders Caused by De Novo Variants in KCNB1 Genotypes and Phenotypes.
    de Kovel CGF; Syrbe S; Brilstra EH; Verbeek N; Kerr B; Dubbs H; Bayat A; Desai S; Naidu S; Srivastava S; Cagaylan H; Yis U; Saunders C; Rook M; Plugge S; Muhle H; Afawi Z; Klein KM; Jayaraman V; Rajagopalan R; Goldberg E; Marsh E; Kessler S; Bergqvist C; Conlin LK; Krok BL; Thiffault I; Pendziwiat M; Helbig I; Polster T; Borggraefe I; Lemke JR; van den Boogaardt MJ; Møller RS; Koeleman BPC
    JAMA Neurol; 2017 Oct; 74(10):1228-1236. PubMed ID: 28806457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARHGEF9 gene variant leads to developmental and epileptic encephalopathy: Genotypic phenotype analysis and treatment exploration.
    Yang H; Liao H; Gan S; Xiao T; Wu L
    Mol Genet Genomic Med; 2022 Jul; 10(7):e1967. PubMed ID: 35638461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic expansion of KCNH1-associated disorders to include isolated epilepsy and its associations with genotypes and molecular sub-regional locations.
    Tian MQ; Li RK; Yang F; Shu XM; Li J; Chen J; Peng LY; Yu XH; Yang CJ
    CNS Neurosci Ther; 2023 Jan; 29(1):270-281. PubMed ID: 36285361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early onset epileptic encephalopathy caused by de novo SCN8A mutations.
    Ohba C; Kato M; Takahashi S; Lerman-Sagie T; Lev D; Terashima H; Kubota M; Kawawaki H; Matsufuji M; Kojima Y; Tateno A; Goldberg-Stern H; Straussberg R; Marom D; Leshinsky-Silver E; Nakashima M; Nishiyama K; Tsurusaki Y; Miyake N; Tanaka F; Matsumoto N; Saitsu H
    Epilepsia; 2014 Jul; 55(7):994-1000. PubMed ID: 24888894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel variants and phenotypes widen the phenotypic spectrum of GABRG2-related disorders.
    Komulainen-Ebrahim J; Schreiber JM; Kangas SM; Pylkäs K; Suo-Palosaari M; Rahikkala E; Liinamaa J; Immonen EV; Hassinen I; Myllynen P; Rantala H; Hinttala R; Uusimaa J
    Seizure; 2019 Jul; 69():99-104. PubMed ID: 31004928
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Li XL; Li ZJ; Liang XY; Liu DT; Jiang M; Gao LD; Li H; Tang XQ; Shi YW; Li BM; He N; Li B; Bian WJ; Yi YH; Cheng CF; Wang J
    Front Mol Neurosci; 2022; 15():860662. PubMed ID: 35600082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP1A1-linked diseases require a malfunctioning protein product from one allele.
    Spontarelli K; Young VC; Sweazey R; Padro A; Lee J; Bueso T; Hernandez RM; Kim J; Katz A; Rossignol F; Turner C; Wilczewski CM; Maxwell GL; Holmgren M; Bailoo JD; Yano ST; Artigas P
    Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119572. PubMed ID: 37659504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.